NCT02290301View on ClinicalTrials.gov

An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin

CompletedOBSERVATIONAL

Enrollment

5,180

Participants

Timeline

Start Date

June 28, 2013

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

gemigliptin

Trial Locations (1)

Unknown

Pusan National University Hospital, Busan

Sponsors

Lead Sponsor

LG Life Sciences

All Listed Sponsors

lead

LG Life Sciences

INDUSTRY